InvestorsHub Logo

biopharm

02/15/14 1:19 PM

#161222 RE: EYEBUYSTOX #161219

maybe even an interesting "abstract title.." could be revealed as well.

accepted abstract titles will be made available online beginning February 19

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97284744

InternetForumUser

02/15/14 10:09 PM

#161265 RE: EYEBUYSTOX #161219

Jeff Masten's Stock Options and Purchases:

Here is a list of all of Jeff Masten's Stock Purchases, Options and their vesting schedules. Not sure if it has any relevance to the February timeframe.

Also besides the 12,498 shares he purchased through EPP, he would need to exercise his shares soon prior to leaving the company. He clearly has a lot of shares he should exercise in a very short time.

May 31, 2011
156,103 Shares at $2.13
Exercisable 5/26/2012
Twenty-five percent of the options vest on each of the first four anniversaries of the date of grant provided that Mr. Masten is employed by Peregrine on the applicable vesting date.


Feb 21, 2012
Date of Earliest Transaction (2/17/2012)
21750 Shares at $0.95
36250 Shares at $0.95
This option vests quarterly over a two year period.


May 1, 2012
12,498 Employee Purchase at $0.40
Shares acquired under the Peregrine employee stock purchase plan on April 30, 2012.


May 8, 2012
Date of Earliest Transaction (5/4/2012)
150,000 Shares at $0.46
This option vests quarterly over a two year period.


Dec 28, 2012
Date of Earliest Transaction (12/27/2012)
150,000 Shares at $1.18
This option vests in eight (8) equal quarterly installments over a two (2) year period beginning March 27, 2013 and each quarter thereafter until fully-vested.

May 8, 2013
Date of Earliest Transaction (5/06/2013)
100,000 Shares at $1.41
This option vests in eight (8) equal quarterly installments over a two (2) year period beginning August 6, 2013 and each quarter thereafter until fully-vested.

freethemice

02/16/14 12:36 AM

#161275 RE: EYEBUYSTOX #161219

Number three is out. Look at a calendar, the 19th is on Wednesday.

freethemice

02/16/14 12:41 AM

#161276 RE: EYEBUYSTOX #161219

Number One is out.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 18, 2014, Mr. Jeffrey L. Masten gave notice of resignation, effective February 20, 2014, as Vice President, Quality of Peregrine Pharmaceuticals, Inc. (the “Company”). The duties performed by Mr. Masten will be reassigned to existing qualified personnel within the Company.